{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-02",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "55910-765",
      "generic_name": "Aspirin",
      "labeler_name": "Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)",
      "brand_name": "Aspirin",
      "active_ingredients": [
        {
          "name": "ASPIRIN",
          "strength": "81 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "55910-765-12",
          "description": "1 BOTTLE, PLASTIC in 1 BOX (55910-765-12)  / 120 TABLET in 1 BOTTLE, PLASTIC",
          "marketing_start_date": "20260515",
          "sample": false
        },
        {
          "package_ndc": "55910-765-30",
          "description": "300 TABLET in 1 BOTTLE, PLASTIC (55910-765-30)",
          "marketing_start_date": "20260515",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)"
        ],
        "rxcui": [
          "308416"
        ],
        "spl_set_id": [
          "3ba0a9f2-062a-401e-82eb-54383a822366"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0359726063302"
        ],
        "nui": [
          "N0000000160",
          "N0000008836",
          "M0001335",
          "N0000175722",
          "N0000175578",
          "N0000008832"
        ],
        "pharm_class_moa": [
          "Cyclooxygenase Inhibitors [MoA]"
        ],
        "pharm_class_pe": [
          "Decreased Prostaglandin Production [PE]",
          "Decreased Platelet Aggregation [PE]"
        ],
        "pharm_class_cs": [
          "Anti-Inflammatory Agents, Non-Steroidal [CS]"
        ],
        "pharm_class_epc": [
          "Nonsteroidal Anti-inflammatory Drug [EPC]",
          "Platelet Aggregation Inhibitor [EPC]"
        ],
        "unii": [
          "R16CO5Y76E"
        ]
      },
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "TABLET",
      "spl_id": "aa58568f-3d77-4544-a3cf-5da0e76dfb05",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20260515",
      "product_id": "55910-765_aa58568f-3d77-4544-a3cf-5da0e76dfb05",
      "application_number": "M013",
      "brand_name_base": "Aspirin",
      "pharm_class": [
        "Anti-Inflammatory Agents",
        "Non-Steroidal [CS]",
        "Cyclooxygenase Inhibitors [MoA]",
        "Decreased Platelet Aggregation [PE]",
        "Decreased Prostaglandin Production [PE]",
        "Nonsteroidal Anti-inflammatory Drug [EPC]",
        "Platelet Aggregation Inhibitor [EPC]"
      ]
    }
  ]
}